Balchem Director Sells 8,000 Shares for $1.2 Million a Week Before a Dividend Hike

David B Fischer directly sold 8,000 shares for a total of ~$1,231,748 on Dec. 3, 2025, at a weighted average price of around $154 per share. This transaction reduced his direct holdings by 50%, leaving him with 7,989 shares.

The Motley Fool • Dec 12, 2025

Balchem Corporation to Present at Baird's 55th Annual Global Industrial Conference on November 12, 2025

MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 55th Annual Global Industrial Conference on November 12, 2025.

GlobeNewsWire • Oct 30, 2025

Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)

I raise my rating for Balchem from "Hold" to "Buy," following my assessment of its performance and prospects. BCPC's 3Q2025 financials exceeded expectations, thanks to the strong showing from its Human Nutrition and Specialty Products segments. I'm anticipating that Balchem can realize growth acceleration in the mid-term by capitalizing on emerging food trends, a new production plant, and promising regulatory developments.

Seeking Alpha • Oct 23, 2025

Why Balchem Stock Jumped Today

Balchem reported record third-quarter sales. The company is growing sales while also supporting new growth initiatives.

The Motley Fool • Oct 21, 2025

Balchem Corporation (BCPC) Q3 2025 Earnings Call Transcript

Balchem Corporation (NASDAQ:BCPC ) Q3 2025 Earnings Call October 21, 2025 11:00 AM EDT Company Participants Carl Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Harris - CEO, President & Chairman Conference Call Participants Bob Labick - CJS Securities, Inc. Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Daniel Harriman - Sidoti & Company, LLC Presentation Operator Thank you for standing by.

Seeking Alpha • Oct 21, 2025

Blachem (BCPC) Q3 Earnings Lag Estimates

Blachem (BCPC) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.03 per share a year ago.

Zacks Investment Research • Oct 21, 2025

Balchem (BCPC) Q3 Earnings Lag Estimates (Revised)

Balchem (BCPC) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.03 per share a year ago.

Zacks Investment Research • Oct 21, 2025

Blachem (BCPC) Moves to Buy: Rationale Behind the Upgrade

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Sep 24, 2025

Scoring Big With Fans: Balchem Spotlights the Power of Vitamin K2 at FC Bayern Women's Season Opener

MONTVALE, N. J.--(BUSINESS WIRE)--Balchem, a global manufacturer of specialty ingredients for human nutrition, has launched its first direct-to-consumer initiative.

Business Wire • Sep 18, 2025

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C.

GlobeNewsWire • Aug 26, 2025